What is the main business of Propharma?

The main business activity of Propharma focuses on wholesale of other food, including fish, crustaceans and molluscs.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 14, 2005.

Where is the headquarters located?

The headquarters is located at: ul. Trzcinowa 27, 02-446 Warszawa.

What is the share capital?

The share capital of the company is PLN 150,000 (approx. $40,519).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of $3,299,548, representing an increase of 12.7% compared to 2024.

Is the company profitable?

No, in 2025 the company was not profitable, reporting a net loss of $128,727. For comparison, in 2024 the loss was $86,377, meaning the company increased its loss by 48.7%.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $1,753,106 in 2025, representing 52% of all operating expenses.

Propharmasp. z o.o.

Wholesale of other food, including fish, crustaceans and molluscs

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2005-01-14

Share capital

150,000.00 PLN

Registered address

ul. Trzcinowa 27, 02-446 Warszawa, Poland

Electronic delivery address

AE:PL-58924-89954-CCFBV-22

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)

$121

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 34 days late).

202508/06/2026
202426/06/2025
202324/06/2024
202207/07/2023
202118/08/2022
202008/09/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 3.30mMedianUSD 983.52kAverageUSD 9.58m

Net profit

This companyUSD -128.73kMedianUSD 15.85kAverageUSD 775.01k

Operating costs

This companyUSD 3.39mMedianUSD 948.35kAverageUSD 8.60m

Assets

This companyUSD 1.09mMedianUSD 418.31kAverageUSD 4.52m

Industry

Trademarks

Propharma holds 26 active trademarks registered with the Polish Patent Office. 1 application is pending. 17 marks have expired or were not registered. The first mark was filed in 2009.

Mark	Number	Classes	Status	Protected until
Magnez+B6 EFFECTIVE Przedłużone uwalnianie składników aktywnych 8h	Z.516440	5, 35	Protected	Jul 24, 2030
PRO Morwa SUPLEMENT DIETY PRAWIDŁOWY POZIOM CUKRU GURMAR, MORWA BIAŁA, FASOLA	Z.510307	5, 35	Protected	Feb 17, 2030
PRO Magnez SUPLEMENT DIETY WYSOKO PRZYSWAJALNY SKŁADNIK AKTYWNY: CYTRYNIAN MAGNEZU	Z.509838	5, 35	Protected	Feb 4, 2030
DR GAJA 70% SOKU BIO SYROP Z WITAMINĄ C O OBNIŻONEJ ZAWARTOŚCI CUKRU MALINA	Z.506784	5, 32	Protected	Nov 14, 2029
DR GAJA BIO SYROP Z WITAMINĄ C 70% SOKU O OBNIŻONEJ ZAWARTOŚCI CUKRU CZARNY BEZ	Z.506781	5, 32	Protected	Nov 14, 2029

Mark	Protected until
Magnez+B6 EFFECTIVE Przedłużone uwalnianie składników aktywnych 8h	Jul 24, 2030
PRO Morwa SUPLEMENT DIETY PRAWIDŁOWY POZIOM CUKRU GURMAR, MORWA BIAŁA, FASOLA	Feb 17, 2030
PRO Magnez SUPLEMENT DIETY WYSOKO PRZYSWAJALNY SKŁADNIK AKTYWNY: CYTRYNIAN MAGNEZU	Feb 4, 2030
DR GAJA 70% SOKU BIO SYROP Z WITAMINĄ C O OBNIŻONEJ ZAWARTOŚCI CUKRU MALINA	Nov 14, 2029
DR GAJA BIO SYROP Z WITAMINĄ C 70% SOKU O OBNIŻONEJ ZAWARTOŚCI CUKRU CZARNY BEZ	Nov 14, 2029

Authorized Representatives

Anna Małgorzata Jędraszczak – Management Board Member

Sebastian Kaliński – Attorney-in-fact (joint)

Magdalena Katarzyna Olczyk – Attorney-in-fact (joint)

Maciej Zygmunt Olczyk – President of the Management Board

Manner of representation

Each member of the management board acting independently is authorized to make declarations of will on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Maciej Zygmunt Olczykage 50	2,752	$37,169.10	91.7333%
Others	248	$3,349.54	8.2667%

Beneficial owners

Person	Rights

Subsidiaries

	Name	Share value	Stake
	Propharma Sciencesp. z o.o.	13,371.15 USD	99%

Bank accounts

Registered as a VAT taxpayer on 2004-10-08.

Alior Bank
57 2490 0005 0000 4600 9085 2801
Alior Bank
67 2490 0005 0000 4600 5021 1561
Alior Bank
64 2490 0005 0000 4600 5945 4066

Debt

No entries in the National Debtors Register (KRZ).

Public aid

66 public aid cases recorded, with a total value of $75,064.

Grant date	Purpose	Gross amount	Granting body
Aug 5, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	$2,009$2,009	Prezes Banku Gospodarstwa Krajowego
Jul 17, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	$4,018$4,018	Prezes Banku Gospodarstwa Krajowego
Aug 5, 2024	De minimis aid (in accordance with Commission Regulation 2023/2831)	$2,005$2,005	Prezes Banku Gospodarstwa Krajowego

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Barilla Polandsp. z o.o.	$26,019,967.53	barilla.com
Sawex FoodsS.A.	$24,241,050.60	sawexfoods.pl
Well Well InvestS.A.	$7,765,227.73	well-well.eu
Foodpaksp. z o.o.	$3,778,871.78	efoodpak.pl
Horeca Asian Foodsp. z o.o.	$3,744,072.12	haf.com.pl
Horeca Asian Food Wrocławsp. z o.o.	$1,135,719.91	haf.com.pl
Genussp. z o.o.	$859,765.41	genus.com.pl
NutrisleP.S.A.	$135,614.44	nutrisle.com
Magellan Foodsp. z o.o.	$65,226.07	magellanfood.eu
Ziarnexsp. z o.o.	$3,738.44	ziarnex.pl

Change history

Date	Event
2024-02-15	Address change (Ul. Łopuszańska 36, 02-220, Warszawa → Ul. Trzcinowa 27, 02-446, Warszawa)
2017-10-11	PKD change (Removed: 46.45.Z, 47.75.Z; Added: 10.86.Z, 10.89.Z)
2015-04-07	Address change (Kierbedzia 4, 00-728, Warszawa → Ul. Łopuszańska 36, 02-220, Warszawa)
2015-04-07	PKD change (Removed: 46 codes)
2014-09-19	PKD change (Removed: 10 codes; Added: 23 codes)

FAQ

Last updated: 2026-06-08